News & Events
- March 22, 2017
-
March 22, 2017
CPTR 2017 Workshop: Day 3 – March 22, 2017
The 8th Annual CPTR Initiative Workshop drew more than 150 participants to Washington, D.C. to learn and share information critical to the rapid advancement of new TB combination therapies, drug susceptibility tests (DST), and the tools and models necessary to develop and implement them. Participants represented a diverse group of global stakeholders, including product developers,... -
March 21, 2017
CPTR 2017 Workshop: Day 2 – March 21, 2017
The 8th Annual CPTR Initiative Workshop drew more than 150 participants to Washington, D.C. to learn and share information critical to the rapid advancement of new TB combination therapies, drug susceptibility tests (DST), and the tools and models necessary to develop and implement them. Participants represented a diverse group of global stakeholders, including product developers,... -
March 20, 2017
Critical Path Institute Launches Type 1 Diabetes Consortium
March 20, 2017 Critical Path Institute Launches Type 1 Diabetes Consortium Tucson, Ariz., March 20, 2017 –Critical Path Institute (C-Path) is pleased to announce the launch of the Type 1 Diabetes (T1D) Consortium. Funded by The Leona M. and Harry B. Helmsley Charitable Trust; Janssen Research & Development, LLC; JDRF International; and Sanofi, the T1D... -
March 20, 2017 - March 23, 2017
2017 CPTR Workshop
Diverse group of TB stakeholders share and learn about new developments in TB drug and drug susceptibility testing research </div The 8th Annual CPTR Initiative Workshop drew more than 150 participants to Washington, D.C. to learn and share information critical to the rapid advancement of new TB combination therapies, drug susceptibility tests (DST), and the...
